May 7, 2025

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]

Read More

Arla Foods Ingredients showcases protein soda concept at Vitafoods Europe

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) — Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Consumers are increasingly seeking functional beverages that support active, balanced lifestyles. According to the Innova Category Survey 2024, nearly 20% […]

Read More

Europe Arla Foods Ingredients นำเสนอแนวคิดโซดาโปรตีน ที่งาน Vitafoods Europe

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) — Arla Foods Ingredients จะเน้นคุณประโยชน์เชิงฟังก์ชันของ pure BLG (เบต้า-แลคโตโกลบูลิน) ในแนวคิดโซดาโปรตีนใหม่ที่งาน Vitafoods Europe แนวคิดโซดาโปรตีน Arla Foods Ingredients แนวคิดโซดาโปรตีน Arla Foods

Read More